Inlyta Approved to Treat Patients with a Type of Advanced Kidney Cancer - Kansas City infoZine PDF Print
Kansas City infoZine
Washington, DC - infoZine - The US Food and Drug Administration approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer. Renal cell carcinoma is a

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.